Body surface potential mapping improves detection of ST segment alteration during percutaneous coronary intervention

International Journal of Cardiology

Volumn 93, Issue 2-3, 2004, Pages 203-210

  Maynard, Suzanne J ^a   Riddell, John W ^a   Menown, Ian B A ^a   Allen, Jim ^b   Anderson, John McC ^b   Khan, Mazhar M ^a   Adgey, A A Jennifer ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Intervention; Ischaemia; Mapping

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RECORDING; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; STENT;

EID: 1242339771     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.03.006     Document Type: Article

References (23)

1. Myocardial infarction redefined - a consenus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. JACC. 36:2000;959-969.
2. Gibler W.B., Young G.P., Hedges J.R.et al. Acute myocardial infarction in chest pain patients with non diagnostic ECGs: serial CK-MB sampling in the emergency department. The emergency medicine cardiac research group. Ann. Emerg. Med. 21:1992;504-512.
3. De Ambroggi L., Bertoni T., Breghi M.L.et al. Diagnostic value of body surface potential mapping in old anterior non-Q myocardial infarction. J. Electrocardiol. 21:1988;321-329.
4. McMechan S.R., Cullen C.M., MacKenzie G.et al. Discriminant function analysis of body surface potential maps in acute myocardial infarction. J. Electrocardiol. 27:1994;117-120. [Suppl.].
5. McMechan S.R., MacKenzie G., Allen J.et al. Body surface ECG potential maps in acute myocardial infarction. J. Electrocardiol. 28:1995;184-190. [Suppl.].
6. Menown I.B.A., Allen J., Anderson J.McC.et al. Early diagnosis of right ventricular or posterior infarction associated with inferior wall left ventricular acute myocardial infarction. Am. J. Cardiol. 85:2000;934-938.
7. Kornreich F., MacLeod R.S., Dzavik V.et al. QRST changes during and after percutaneous transluminal coronary angioplasty. J. Electrocardiol. 27:1994;113-116. [Suppl.].
8. Shenasa M., Hamel D., Nasmith Jet al. Body surface potential mapping of ST-segment shift in patients undergoing percutaneous transluminal coronary angioplasty. Correlations with the ECG and vectorcardiogram. J. Electrocardiol. 26:1993;43-51.
9. Preda I., Nadeau R., Savard P.et al. QRS alterations in body surface potential distributions during percutaneous transluminal coronary angioplasty in single-vessel disease. J. Electrocardiol. 27:1994;311-322.
10. Spekhorst H., SippensGroenewegen A., David G.K.et al. Body surface mapping during percutaneous transluminal coronary angioplasty. QRS changes indicating regional myocardial conduction delay. Circulation. 81:1990;840-849.
11. Menown I.B.A., Patterson R.S.H.W., MacKenzie G.et al. Body-surface map models for early diagnosis of acute myocardial infarction. J. Electrocardiol. 31:1998;180-188. [Suppl.].
12. Riddell J.W., Smith B.A., Menown I.B.A., Maynard S.J., Manoharan G., Allen J.et al. Body surface mapping in ischaemic heart disease. Belfast. 2001;9.
13. Prineas R.J., Crow R.S., Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. 1982;John Wright, PSG, Boston.
14. Kornreich F., Montague T.J., Rautaharju P.M. Body surface potential mapping of ST segment changes in acute myocardial infarction. Implications for ECG enrollment criteria for thrombolytic therapy. Circulation. 87:1993;773-782.
15. Wung S.F., Drew B. Comparison of 18-lead ECG and selected body surface potential mapping leads in determining maximally deviated ST lead and efficacy in detecting acute myocardial ischaemia during coronary occlusion. J. Electrocardiol. 32:1999;30-37. [Suppl.].
16. Wung S.F., Lux R.L., Drew B.J. Thoracic location of the lead with maximal ST-segment deviation during posterior and right ventricular ischaemia: comparison of 18-lead ECG with 192 estimated body surface leads. J. Electrocardiol. 33:2000;167-174. [Suppl.].
17. Montague T.J., Witkowski F.X., Miller R.M.et al. Persistent changes in the body surface electrocardiogram following successful coronary angioplasty. J. Electrocardiol. 22:1994;91-98. [Suppl.].
18. Boudik F., Stojan M., Anger Z.et al. Evaluation of body surface potential mapping changes after successful percutaneous transluminal coronary angioplasty. Can. J. Cardiol. 12:1996;745-749.
19. Tilser P., Malkova A., Valova D.et al. Body surface potential mapping (BSPM) before and after percutaneous transluminal coronary angioplasty (PTCA). Physiol. Res. 42:1993;131-134.
20. Ogawa S., Fukazawa R., Ohkubo T.et al. Silent myocardial ischaemia in Kawasaki disease: evaluation of percutaneous transluminal coronary angioplasty by dobutamine stress testing. Circulation. 96:1997;3384-3389.
21. Abdelmeguid A.E., Whitlow P.L., Sapp S.K.et al. Long term outcome of transient uncomplicated in-laboratory coronary artery closure. Circulation. 91:1995;2733-2741.
22. Solymoss B.C., Cote G., Leung T.K.et al. Pathology of PTCA complications. Circulation. 78(Suppl. II):1988;449.
23. MacLeod R.S., Brooks D.H., On H.et al. Analysis of PTCA-induced ischaemia using an ECG inverse solution or the wavelet transform. J. Electrocardiol. 27:1994;93-100. [Suppl.].